15:59 Jun 03

Hikal Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
187.98
-3.44 (-1.80%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Hikal Ltd. Financials

Hikal Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
187.98
-3.44 (-1.80%)
15:59 Jun 03
Quality
image/svg+xml

36/100
Medium Financial Strength

Valuation
image/svg+xml

31/100
Mid Valuation

Technical

40/100
Technically Neutral

Strength

7

Weakness

8

Opportunity

0

Threats

0

-4.07 %

ROE %

-2.06 %

ROA %

-3.96

EPS

97.07

BVPS

-2.84 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
1942.72 2023.03 1784.6 1859.8 1712.6
Operating Expenses +
1602.16 1765.97 1517.57 1531.4 1492.2
Raw Material
1032.21 1121.59 805.15 882.7 798.6
Increase Decrease in Cost
-35.82 -14.56 19.51 -45.4 -36.9
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
203.38 222.44 246.53 247.1 270.3
Miscellaneous Expenses
402.39 436.5 446.38 447 460.2
Operating Profit
340.56 257.06 267.03 328.4 220.4
Other Income
4.89 5.41 2.45 5 12.3
Depreciation
95.67 109.01 117.61 134.4 163.8
Interest
31.22 48.1 56.37 75.2 62.1
Profit before tax and exceptio..
218.56 105.36 95.5 123.8 6.8
Exceptional Items
0 0 0 0 -85.1
PBT
218.56 105.36 95.5 123.8 -78.3
Provision for Taxation
58.06 26.98 25.9 33 -29.5
Net Profit
160.5 78.38 69.6 90.8 -48.8
NET Profit after MI
160.5 78.38 69.6 90.8 -48.8
EPS
13.02 6.36 5.64 7.36 -3.96
Operating Profit Margin (%)
17.53 12.71 14.96 17.66 12.87
Net Profit Margin (%)
8.26 3.87 3.9 4.88 -2.85

Hikal Ltd. Shareholding

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 68.80 68.80 68.80 68.80 68.80 68.80
FII 1.40 2.30 4.20 5.40 5.70 6.10
Public 7.20 7.10 5.20 4.00 3.80 3.40
Others 22.60 21.80 21.80 21.80 21.70 21.70
Shareholder Shares Holding %
Download Our App On: